Option Care Health (NASDAQ:OPCH) Stock Moved Down to "Hold" by Barrington Research

Key Points

• Barrington Research downgraded Option Care Health from “outperform” to “hold,” joining a broader analyst consensus of “Hold” with an average price target of $29.70.
• Option Care Health exceeded quarterly expectations, reporting $0.45 in EPS versus $0.43 forecast and $1.44 billion in revenue, up 1.9% year over year.
• CD&R and McKesson agreed to acquire the company for approximately $5.8 billion, providing a near-term valuation catalyst, though shareholder-rights investigations could create headline risk or delay completion.

Option Care Health (NASDAQ:OPCH - Get Free Report) was downgraded by stock analysts at Barrington Research from an "outperform" rating to a "hold" rating in a research report issued to clients and investors on Wednesday, Marketbeat reports.

Several other analysts also recently issued reports on the company. Deutsche Bank Aktiengesellschaft reissued a "hold" rating and issued a $24.00 price target (down from $26.00) on shares of Option Care Health in a report on Thursday, July 30th. Wall Street Zen raised Option Care Health from a "hold" rating to a "buy" rating in a report on Saturday, August 1st. Zacks Research upgraded Option Care Health from a "strong sell" rating to a "hold" rating in a research report on Monday, July 6th. William Blair downgraded shares of Option Care Health from an "outperform" rating to a "market perform" rating in a report on Tuesday. Finally, Weiss Ratings upgraded shares of Option Care Health from a "sell (d+)" rating to a "hold (c-)" rating in a research report on Friday, September 11th. Three investment analysts have rated the stock with a Buy rating and thirteen have issued a Hold rating to the stock. According to MarketBeat.com, Option Care Health currently has an average rating of "Hold" and an average price target of $29.70.

Option Care Health Stock Performance

Shares of OPCH stock opened at $31.01 on Wednesday. The company has a debt-to-equity ratio of 0.91, a quick ratio of 0.98 and a current ratio of 1.47. The stock has a market capitalization of $4.64 billion, a price-to-earnings ratio of 23.32, a PEG ratio of 1.79 and a beta of 0.58. Option Care Health has a one year low of $18.01 and a one year high of $36.80. The company's 50-day simple moving average is $23.92 and its 200-day simple moving average is $23.57.

Option Care Health (NASDAQ:OPCH - Get Free Report) last issued its quarterly earnings results on Wednesday, July 29th. The company reported $0.45 earnings per share for the quarter, beating analysts' consensus estimates of $0.43 by $0.02. Option Care Health had a return on equity of 18.74% and a net margin of 3.68%.The business had revenue of $1.44 billion during the quarter, compared to the consensus estimate of $1.42 billion. During the same period in the previous year, the business earned $0.41 EPS. The business's quarterly revenue was up 1.9% on a year-over-year basis. Option Care Health has set its FY 2026 guidance at 1.850-1.920 EPS. Equities analysts anticipate that Option Care Health will post 1.7 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

A number of hedge funds have recently bought and sold shares of OPCH. Harbor Investment Advisory LLC bought a new stake in Option Care Health in the second quarter worth about $48,000. Nykredit A S bought a new position in shares of Option Care Health during the 2nd quarter valued at about $56,000. Public Employees Retirement System of Ohio bought a new position in shares of Option Care Health during the 2nd quarter valued at about $66,000. KBC Group NV grew its stake in shares of Option Care Health by 22.1% in the 1st quarter. KBC Group NV now owns 5,453 shares of the company's stock worth $147,000 after purchasing an additional 988 shares during the last quarter. Finally, Summitry LLC acquired a new position in shares of Option Care Health in the 1st quarter worth approximately $200,000. 98.05% of the stock is owned by institutional investors and hedge funds.

Key Stories Impacting Option Care Health

Here are the key news stories impacting Option Care Health this week:

• Positive Sentiment: CD&R and McKesson agreed to acquire Option Care Health for approximately $5.8 billion, providing a clear near-term valuation catalyst and largely explaining the sharp rally in OPCH shares. CD&R and McKesson Corporation Sign Agreement to Acquire Option Care Health
• Positive Sentiment: Unusually heavy call-option activity, with 5,219 calls purchased versus typical volume of 281, indicates heightened bullish and deal-related speculation. However, options activity is not a guarantee that the transaction will close.
• Neutral Sentiment: JPMorgan reaffirmed its “neutral” rating while raising its price target to $33, and Citizens JMP and Barrington Research maintained “market perform” ratings. These views suggest limited fundamental upside beyond the cash offer absent a competing bid.
• Neutral Sentiment: Truist downgraded Option Care Health from “strong buy” to “hold,” likely reflecting the reduced upside after the buyout announcement rather than a deterioration in the company’s operating performance.
• Negative Sentiment: Several shareholder-rights law firms are investigating whether the $32.05 offer fairly values OPCH and whether insiders may receive benefits unavailable to public shareholders. Such reviews could increase headline risk or delay the transaction, although they do not by themselves indicate that the deal will fail. Ademi LLP OPCH Shareholder Alert

About Option Care Health

Option Care Health, Inc NASDAQ: OPCH is a provider of home and alternate-site infusion services in the United States. The company works with patients, physicians, hospitals, health plans and pharmaceutical manufacturers to deliver and manage infusion therapy outside traditional hospital settings, including in patients' homes, ambulatory infusion suites and other community-based locations.

Its services include the provision and administration of specialty medications and other infusion therapies for conditions such as infections, immune disorders, chronic diseases and nutritional deficiencies.